Abstract
135 Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of JNJ-26481585, a second generation histone deacetylase inhibitor
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1359-6349(10)71840-1
Journal: EJC Supplements | Publication Date: Nov 1, 2010 |
135 Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of JNJ-26481585, a second generation histone deacetylase inhibitor
Join us for a 30 min session where you can share your feedback and ask us any queries you have